Publications by authors named "Tim Ashwood"

Claim this Profile
R
Rapid decline in episodic memory in healthy older adults with high amyloid-β.
Yen Ying Lim, Robert H Pietrzak, Kathryn A Ellis, Judith Jaeger, Karra Harrington, Tim Ashwood

J Alzheimers Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
Yen Ying Lim, Judith Jaeger, Karra Harrington, Tim Ashwood, Kathryn A Ellis

Arch Clin Neuropsychol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-amyloid dynamics in human plasma.
Yafei Huang, Rachel Potter, Wendy Sigurdson, Tom Kasten, Rose Connors, Tim Ashwood

Arch Neurol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.
Lutz Frölich, Tim Ashwood, Jonas Nilsson, Göran Eckerwall,

J Alzheimers Dis· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measure.
Nishant K Mishra, Ashfaq Shuaib, Patrick Lyden, Hans-Christoph Diener, James Grotta, Tim Ashwood

Stroke· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Hans-Christoph Diener, Kennedy R Lees, Patrick Lyden, Jim Grotta, Antoni Davalos, Tim Ashwood

Stroke· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
Patrick D Lyden, Ashfaq Shuaib, Kennedy R Lees, Antoni Davalos, Stephen M Davis, Tim J Ashwood

Stroke· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NXY-059 for the treatment of acute ischemic stroke.
Ashfaq Shuaib, Kennedy R Lees, Patrick Lyden, James Grotta, Antonio Davalos, Tim Ashwood

N Engl J Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.
Kennedy R Lees, Antonio Davalos, Stephen M Davis, Hans-Christoph Diener, James Grotta, Tim Ashwood

Stroke· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.
A Richard Green, Kerstin Lanbeck-Vallén, Tim Ashwood, Stefan Lundquist, Eva Lindström Böö

Brain Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NXY-059 for acute ischemic stroke.
Kennedy R Lees, Justin A Zivin, Tim Ashwood, Antonio Davalos, Stephen M Davis

N Engl J Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
A Richard Green, Tim Ashwood

Curr Drug Targets CNS Neurol Disord· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes.
Patrick Lyden, Lennart Claesson, Suzanne Havstad, Tim Ashwood, Mei Lu

Arch Neurol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke.
Brett L Cucchiara, Scott E Kasner, David A Wolk, Patrick D Lyden, Volker A Knappertz, Tim Ashwood

Crit Care Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.
A Richard Green, Tim Ashwood, Tomas Odergren, David M Jackson

Pharmacol Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.
Per-Henrik Zingmark, Marianne Ekblom, Tomas Odergren, Tim Ashwood, Patrick Lyden

Br J Clin Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of stroke: do they have value for discovering neuroprotective agents?
A Richard Green, Tomas Odergren, Tim Ashwood

Trends Pharmacol Sci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis